If you want the strongest evidence on medical cannabis for epilepsy, start with the randomized, placebo-controlled trials of purified cannabidiol (CBD) that led to FDA approval for Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. That body of research is the benchmark. Everything below is ranked against four criteria: study design, how clearly the patient group was defined, whether results were repeated across sites, and whether the findings transfer to a product a real person can walk in and buy.

best cbd thc ratio for seizures

1. Randomized Trials of Purified CBD (Top Pick)

These are the trials regulators reviewed before approving a prescription CBD oral solution. They enrolled children and adults with rare, treatment-resistant epilepsy syndromes, compared add-on CBD to add-on placebo, and counted seizure frequency over a fixed window.

Clinical Trial Cannabis for Intractable Epilepsy: What to Expect

Pros

  • Placebo controls and blinding reduce the chance that hope alone explains the result.
  • Patient groups are defined by specific syndromes rather than a vague label of epilepsy.
  • Results were replicated in more than one trial and reviewed by regulators.
  • Adverse events and drug interactions were tracked and reported.

Cons

  • The studies cover a narrow set of severe, early-onset syndromes, not every seizure type.
  • They tested one purified formulation, not flower, tinctures, or full-spectrum extracts.
  • Follow-up windows were relatively short compared with a lifetime of treatment.
  • Side effects are real, including sleepiness, appetite changes, liver enzyme elevations, and raised levels of some co-prescribed seizure medicines.

Best for: a family deciding whether a prescription CBD product is worth discussing with a neurologist. This is the literature your doctor is most likely to know.

Where to Get a Medical Cannabis Card for Epilepsy

2. Cochrane Systematic Reviews

Cochrane reviews pool the available trials on cannabis-based medicines for epilepsy and grade how confident we can be in the combined result.

Cannabis for Epilepsy: Side Effects, Interactions, and What to Ask

Pros

  • Aggregates many small studies into one readable summary.
  • States clearly where evidence is weak or missing.
  • Updated as new trials appear.

Cons

  • Conclusions can shift between versions as studies are added.
  • Pooled trials often used different products, doses, and seizure definitions, which muddies comparison.
  • Plain-language summaries are useful but still leave dosing questions open.

Best for: a reader who wants the big picture before a doctor visit, or who is comparing what different clinics claim.

3. Neurology Society Systematic Review and Guideline Summary

A major neurology professional society published a systematic review that graded cannabis-based treatments by evidence level and by epilepsy type.

Pros

  • Written for clinicians, so it sorts strong evidence from weak.
  • Covers multiple forms of cannabis, not CBD alone.
  • Gives a framework for talking about risk and monitoring.

Cons

  • Older than the newest trials, so it does not include every recent result.
  • It summarizes evidence rather than telling you what to take.
  • Findings on smoked or inhaled cannabis remain limited.

Best for: someone who wants to know why a neurologist recommends one product category over another.

4. Observational Studies and Patient Registries

Registries follow real patients using real products over months and years, often with parent-reported seizure counts.

Pros

  • Reflects products people actually use, including artisanal extracts.
  • Captures longer-term use and quality-of-life outcomes.
  • Can flag safety signals that short trials miss.

Cons

  • No placebo group, so improvement cannot be attributed to cannabis with confidence.
  • Recall bias and self-report weaken the seizure counts.
  • Product labels in this space are not always accurate, which makes dose unknown.

Best for: understanding everyday experiences and side effects, not for proving that a product works.

What This Means at a Cannabis Store

The CBD used in the trials was a prescription medicine, and the strength, purity, and dosing were controlled. What sits on a dispensary shelf is a different category of product, and state medical cannabis programs vary in what they allow. If you are researching this for yourself or a family member, bring the study language with you, ask for a certificate of analysis on any product, and never change a seizure medication without the prescriber. Store staff can explain product types and ratios, but they cannot tell you what will control seizures.

Choosing What to Read Next

For treatment decisions, use the randomized trial literature and the neurology guideline summary. For context and lived experience, read the registries, but weigh them as description rather than proof. If a source cannot tell you who was studied, how seizures were counted, and what product was used, treat it as a starting point for a conversation, not a conclusion.